• Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study 

      Ratajczak-Tretel, Barbara; Lambert, Anna Tancin; Al-Ani, Riadh Ibrahim Mahmud; Arntzen, Kathrine Grønning; Bakkejord, Grete; Bekkeseth, Hanna Marie Otterholt; Bjerkeli, Vigdis; Eldøen, Guttorm; Gulsvik, Anne Kristine; Halvorsen, Bente; Høie, Gudrun; Ihle-Hansen, Hege Beathe; Ihle-Hansen, Håkon; Ingebrigtsen, Susanne; Kremer, C.; Krogseth, Siv Bohne; Kruuse, C.; Kurz, Martin; Nakstad, Ingvild; Novotny, Vojtech; Næss, Halvor; Qazi, Rehman Ul-Haq; Rezaj, M.K.; Rørholt, Dag Marius Nitschke; Steffensen, Linn Hofsøy; Sømark, Jesper Norsted; Tobro, Håkon; Truelsen, T.C.; Wassvik, L.; Ægidius, K.L.; Atar, Dan; Aamodt, Anne Hege (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-05-10)
      Background - Atrial fibrillation (AF) detection and treatment are key elements to reduce recurrence risk in cryptogenic stroke (CS) with underlying arrhythmia. The purpose of the present study was to assess the predictors of AF in CS and the utility of existing AF-predicting scores in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study.<p> <p>Method - The NOR-FIB study was an international ...
    • Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke. Results From NOR-TEST 

      Kvistad, Christopher Elnan; Novotny, Vojtech; Kurz, Martin; Rønning, Ole M.; Thommessen, Bente; Carlsson, Maria; Waje-Andreassen, Ulrike; Næss, Halvor; Thomassen, Lars; Logallo, Nicola (Journal article; Tidsskriftartikkel; Peer reviewed, 2019-04-08)
      <p><i>Background and Purpose — </i>Tenecteplase represents a promising alternative to alteplase as thrombolytic treatment in acute ischemic stroke. There are limited data on tenecteplase 0.4 mg/kg in patients with increased stroke severity. We aimed to assess safety and efficacy of tenecteplase 0.4 mg/kg in patients with moderate and severe ischemic stroke. <p><i>Methods — </i>NOR-TEST (Norwegian ...